-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701.P1.41 701. Experimental Transplantation: Basic and Translational: Poster I

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Fundamental Science, Apoptosis, Research, Translational Research, Genomics, Immune mechanism, Immunology, Metabolism, Biological Processes, Microbiome, Multi-systemic interactions, Pathogenesis
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Jonah Pierce1,2,3*, Brianna Gipson2*, Lucia Serrano-Marin, MSc4*, Kimon V Argyropoulos, MD PhD5*, Susan DeWolf, MD6, Scott E. James, MD, PhD1, Manpreet Kaur, BS1*, Anastasia Kousa, PhD1*, Chi L Nguyen, PhD1,7*, Adhithi Rajagopalan, PhD1*, Kristen Victor, BA2*, Kenyon Weis8*, Andri Leo L Lemarquis, MD, PhD1* and Marcel R.M. van den Brink, MD, PhD9

1City of Hope National Medical Center, Duarte, CA
2Memorial Sloan Kettering Cancer Center, New York, NY
3Immunology and Microbial Pathogenesis, Weill Cornell Graduate School of Medicine, New York, NY
4Department of Immunology, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Gerstner Sloan Kettering Graduate School of Biomedical Sciences, New York, NY
8Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA

Rogers Nahui Palomino, PhD1*, Etsuko Yasuda, PhD2*, Nienke Haverkate, MSC2*, Hergen Spits, PhD2*, Tim Beaumont, PhD3*, Bianca Blom, PhD2* and Mette D. Hazenberg, MD, PhD2,4,5*

1Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, AL, Netherlands
2Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
3Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
4Department of Hematopoiesis, Sanquin Research, Amsterdam, Netherlands
5Department of Hematology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands

Hao Yan, PhD1, Xiangyue Zhang, PhD2*, Jeanette Baker, PhD1*, Edgar G. Engleman, MD2,3* and Robert S. Negrin, MD4

1Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
2Department of Pathology, School of Medicine, Stanford University, Palo Alto, CA
3Stanford Cancer Institute, Stanford University, Palo Alto, CA
4Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Huidong Guo1*, Xinya Jiang2,3*, Zhigui Wu2*, Fangqing Zhang2*, Qianqian Huang, PhD2*, Bixia Wang2* and Xiao Jun Huang, MD4,5,6

1*Correspondence should be addressed to Xiao-Jun Huang or Huidong Guo, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China
2Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China
3Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciencesv, Beijing, China
4Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
5Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China
6Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Stefan Radtke, PhD1, Kyle Swing2*, George S. Laszlo, PhD2,3*, Andrea Repele, PhD2*, Greta N. Kanestrom3*, Nicholas E Petty2*, Donald K. Hamlin4*, D. Scott Wilbur, PhD4*, Brenda M. Sandmaier, MD5, Hans-Peter Kiem, MD, PhD1 and Roland B. Walter, MD, PhD, MS1

1Fred Hutchinson Cancer Center, Seattle, WA
21100 Fairview Avenue North, Fred Hutchinson Cancer Center, Seattle, WA
31100 Fairview Avenue North, Fred Hutchinson Cancer Center, Seattle
4Department of Radiation Oncology, University of Washington, Seattle, WA
5Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA

Charmaine Fay Soco, PhD1, Mark R. Krampf1,2*, Yan Yi Chan3*, Hana Hoang, MS1,2*, Nivedita Kunte, BHMS4*, Gopin Saini, MBBS5,6*, Kenneth I. Weinberg, MD1*, Robertson Parkman, MD7,8, Alice Bertaina, MD, PhD5,6,9, Rajni Agarwal, MD1,5,10,11*, Matthew Porteus, MD, PhD5,6,9,12 and Agnieszka D. Czechowicz, MD, PhD1,2,5,10

1Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
2Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
3Department of Pediatrics; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
4Department of Pediatrics; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University, Palo Alto, CA
5Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
6Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
7Stanford University School of Medicine, Stanford
8Department of Pediatrics; Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Pebble Beach, CA
9Lucile Packard Children’s Hospital, Palo Alto, CA
10Lucile Packard Children’s Hospital, Palo Alto
11Center for Definitive and Curative Medicine, Stanford University, Stanford, CA
12Stanford Medical School, Stanford, CA

Felicia Kemp, MA1*, Gail Waltz, MD1*, Rebecca Brown2* and Craig Byersdorfer, MD1

1University of Pittsburgh, Pittsburgh, PA
2University of Pittsburgh, West Reading, PA

Dejene Tufa, DVM1*, Eric Hoffmeyer2*, Kristin Schaller1*, Ben Kooiman2*, Elena Woods3*, Dong Wang1*, Dallas Jones4*, Spencer Hall5* and Michael R Verneris, MD6

1UC Denver, Aurora, CO
2University of Colorado Anschutz Medical Campus, Aurora, CO
3CU Anschutz/Pediatrics, GREENWOOD VILLAGE, CO
4University of Colorado, Denver, Aurora, CO
5CU Anschutz, Aurora, CO
6Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Colorado School of Medicine and Children's Hospital of Colorado, Aurora, CO

Michael AG Kern1*, Rèmi Doucet Ladevèze2*, Haroon Shaikh, PhD1*, Mariachiara Aloisi3*, Muthita Khamwong3*, Juan Vargas4*, Shreeya Tavkari3*, Hermann Einsele, MD5, Mercedes Gomez de Agüero, PhD3* and Andreas Beilhack6*

1Department of Medicine II, University Hospital Würzburg, Würzburg, Germany
2Institute for Systemsimmunology, University of Würzburg, Würzburg, Germany
3University Würzburg, Würzburg, Germany
4University Hospital Würzburg, Würzburg, Germany
5Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
6Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Stephen P. Persaud, MD, PhD1, Aditya R. Yelamali, B.A.2*, Julie K. Ritchey2* and John F. DiPersio, MD, PhD3

1Department of Pathology & Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, Saint Louis, MO
2Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
3Washington University School of Medicine, St Louis, MO

Lee-Kai Sun, BS1,2, Archana Ramgopal, DO3, Erica Braverman, MD4, Darlene Monlish, Ph.D.4*, Christopher Wittmann4*, Manda Ramsey4*, Richard Caitley5*, William Hawse, Ph.D.5* and Craig Byersdorfer, MD6

1University of Pittsburgh School of Medicine, Pittsburgh
2UPMC, Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA
3Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
4UPMC, Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA
5University of Pittsburgh, Department of Immunology, Pittsburgh, PA
6University of Pittsburgh, Pittsburgh, PA

Stephanie N Hurwitz, MD, PhD1,2, Danielle R Kobulsky, PSM3*, Seul K Jung, BS4*, Jason M Butler, PhD5 and Peter Kurre, MD6,7

1Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
2Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
3Division of Hematology, The Children's Hospital of Philadelphia, Philadelphia, PA
4Cell & Molecular Biology Graduate Group, University of Pennsylvania, Philadelphia, PA
5Division of Hematology/Oncology, University of Florida, Gainesville, FL
6Children's Hospital of Philadelphia, Philadelphia, PA
7Department of Pediatrics, University of Pennsylvania, Philadelphia, PA

Sabrina A. Becker, MSc1*, Julius C. Enssle, MD2,3,4*, Anne C. Wilke, MD2,3,5*, Sylvia Pfundt2*, Nico Zeltner2*, Ana Jankovic2*, Sebastian Wolf, MD2,3,5,6*, Thomas A. Wichelhaus, MD2,7*, Volkard A. J. Kempf, MD2,7*, Maria J. G. T. Vehreschild, MD2,8*, Hubert Serve, MD2,4,9,10, Thomas Oellerich, MD2,4,6,11*, Björn Steffen, MD2,3,4* and Sebastian Scheich, MD2,3,4,10*

1Goethe University Frankfurt, University Hospital, Frankfurt Am Main, AA, Germany
2Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany
3German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, Frankfurt am Main, Germany
4University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany
5University Cancer Center (UCT) Frankfurt, University Hospital, Frankfurt am Main, Germany
6Frankfurt Cancer Institute, Goethe University, Frankfurt, Germany
7Institute of Medical Microbiology and Infection Control, University Hospital Frankfurt, Frankfurt am Main, Germany
8Department of Internal Medicine II, Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany
9German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Frankfurt, Germany
10Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany
11German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, German Cancer Research Center (DKFZ), Heidelberg, Germany

Haroon Shaikh, PhD1*, Cindy Flamann, PhD2,3*, Carina Matos, PhD4*, Hla Ali, MSc5*, Michael AG Kern1*, Marina Kreutz, PhD4*, Maike Buettner-Herold6*, Christopher Lischer, MSc2*, Simon Voelkl, PhD7,8,9,10*, Christian Kellner, PhD11*, Katrin Bitterer, MTA2*, Domenica Saul, MTA2*, Ernst Holler, MD, PhD12*, Alma Zernecke, MD5*, Dimitrios Mougiakakos, MD13, Andreas Beilhack14* and Heiko Bruns, PhD8,9,15*

1Department of Medicine II, University Hospital Würzburg, Würzburg, Germany
2Department of Internal Medicine 5 – Hematology/Oncology, University Hospital Erlangen, Erlangen, Germany
3University Hospital Erlangen, Erlangen, DEU
4Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany
5Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany
6Department of Nephropathology, University Hospital Erlangen, Erlangen, Germany
7Department of Internal Medicine 5 - Hematology and Oncology, University Hospital of Erlangen, Erlangen, Germany
8Bavarian Cancer Research Center (BZKF), Erlangen, Germany
9Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany
10Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
11Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU University Hospital, LMU Munich, Munich, Germany
12Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
13Department of Hematology, Oncology and Cell Therapy, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany
14Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
15Department of Internal Medicine 5, Hematology and Oncology, University of Erlangen, Erlangen, Bavaria, Germany

*signifies non-member of ASH